Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

Item
http://www.wikidata.org/entity/Q53598172
The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting GuidelinesFirst-Generation Versus Second-Generation Drug-Eluting Stents in Coronary Chronic Total Occlusions: Two-Year Results of a Multicenter RegistryGastroscopy-related adverse cardiac events and bleeding complications among patients treated with coronary stents and dual antiplatelet therapyEvaluation of algorithms for registry-based detection of acute myocardial infarction following percutaneous coronary interventionInfluence of Late Vascular Inflammation on Long-Term Outcomes Among Patients Undergoing Implantation of Drug Eluting Stents: Role of C-Reactive Protein.Longitudinal deformation of a third generation zotarolimus eluting stent: "The concertina returns!"Surgical versus percutaneous revascularization in patients with multivessel coronary artery disease.The year in cardiology 2014: coronary intervention.Long-term (2-5 years) adverse clinical outcomes associated with ZES versus SES, PES and EES: A Meta-Analysis.How can the research potential of the clinical quality databases be maximized? The Danish experience.Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study.A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry.Safety and Efficacy of the Endeavor Resolute® Stent in Patients with Multivessel Disease: The HEART (Honam EndeAvor ResoluTe) Prospective, Multicenter Trial.Deliver the drug and be resorbed: evidence from ABSORB Japan.Myocardial infarction with non-obstructive thrombus validated by optical coherence tomography.
P2860

Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

Item
http://www.wikidata.org/entity/Q53598172
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Differential clinical outcomes ...... randomised superiority trial.
@en
Differential clinical outcomes ...... randomised superiority trial.
@nl
type
label
Differential clinical outcomes ...... randomised superiority trial.
@en
Differential clinical outcomes ...... randomised superiority trial.
@nl
prefLabel
Differential clinical outcomes ...... randomised superiority trial.
@en
Differential clinical outcomes ...... randomised superiority trial.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Differential clinical outcomes ...... randomised superiority trial.
@en
P2093
P304
P31
P356
10.1016/S0140-6736(14)60405-0
P407
P433
P478
P50
P577
P698